Bristol Myers Squibb tops earnings estimates and hikes outlook, helped by Eliquis and new drugs

The pharmaceutical giant also raised its full-year revenue forecast to an increase of more than 5%.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.